by European Society of Human Genetics Arteriovenous malformation. Credit: Hellerhoff/Wikimedia Commons, CC BY 3.0 The same property of thalidomide that caused birth defects when it was given to pregnant women—the inhibition of blood vessel formation (anti-angiogenesis)—has led to an interest in thalidomide’s therapeutic utility in other fields. At the annual conference of the European Society for Human...
